These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 825898)

  • 1. Alterations in the effects of dopamine agonists and antagonists on general activity in rats following chronic morphine treatment.
    Smee ML; Overstreet DH
    Psychopharmacology (Berl); 1976 Sep; 49(2):125-30. PubMed ID: 825898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of antinociceptive action of morphine by dopamine agonist and antagonist in mice.
    Kamata K; Ogawa K; Kameyama T
    Jpn J Pharmacol; 1985 May; 38(1):113-5. PubMed ID: 4021227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.
    Dewey KJ; Fibiger HC
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):261-70. PubMed ID: 6683359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ; Franklin KB
    Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential enhancement of locomotor activity by dopamine agonists following chronic morphine treatment.
    Tye NC; Horsman L; Wright FC; Pullar IA
    Psychopharmacology (Berl); 1979 May; 63(3):313-5. PubMed ID: 39310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
    De Deurwaerdère P; Cervo L; Stinus L; Spampinato U
    Pharmacol Biochem Behav; 2002 Apr; 71(4):627-33. PubMed ID: 11888554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supersensitivity to dopaminergic agonists induced by haloperidol.
    Thornburg JE; Moore KE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):23-8. PubMed ID: 1241913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
    Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
    Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of dopaminergic mechanism in morphine induced Straub tail response.
    Jaju BP; Srivastava YP
    Indian J Exp Biol; 1984 Aug; 22(8):424-7. PubMed ID: 6510975
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic involvement in the mediation of morphine effects on vocalization and movement reactivity in the rat.
    Kiyatkin EA; Zhukov VN
    Int J Neurosci; 1991 May; 58(1-2):1-5. PubMed ID: 1938171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH; Wilcox RE; Vaughn DM; Smith RV
    Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine induced stereotypic behavior in rat.
    Charness ME; Amit Z; Taylor M
    Behav Biol; 1975 Jan; 13(1):71-80. PubMed ID: 1167447
    [No Abstract]   [Full Text] [Related]  

  • 15. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine.
    Vezina P; Stewart J
    Brain Res; 1989 Oct; 499(1):108-20. PubMed ID: 2679971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
    Dunstan R; Jackson DM
    Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of baclofen on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity.
    Woo SH; Kim HS; Yun JS; Lee MK; Oh KW; Seong YH; Oh SK; Jang CG
    Pharmacol Res; 2001 Apr; 43(4):335-40. PubMed ID: 11352538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area.
    Kamata K; Rebec GV
    Life Sci; 1984 Jun; 34(24):2419-27. PubMed ID: 6727576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats.
    Ettenberg A; Milner PM
    Pharmacol Biochem Behav; 1977 Dec; 7(6):507-14. PubMed ID: 563603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.